Dow Up0.11% Nasdaq Up0.50%

Gilead Sciences Inc. (GILD)

-NasdaqGS
107.56 Up 0.05(0.05%) Aug 29, 4:00PM EDT
|After Hours : 107.79 Up 0.23 (0.21%) Aug 29, 7:58PM EDT
ProfileGet Profile for:
Gilead Sciences Inc.
333 Lakeside Drive
Foster City, CA 94404
United States - Map
Phone: 650-574-3000
Fax: 650-578-9264
Website: http://www.gilead.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:6,100

Business Summary 

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. The company’s products include Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Sovaldi, Viread, and Hepsera products for the treatment of liver disease. It also offers Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; Vistide, an antiviral injection for the treatment of cytomegalovirus retinitis in adult patients with AIDS; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages for the treatment of HIV, liver, oncology/inflammation, cardiovascular, and respiratory diseases. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaborations with BMS, Janssen, and Japan Tobacco to develop and commercialize various products. The company was founded in 1987 and is headquartered in Foster City, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Gilead Sciences Inc.

Corporate Governance 
Gilead Sciences Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 2. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 4; Compensation: 4.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Dr. John C. Martin Ph.D., 62
Chairman and Chief Exec. Officer
5.12M158.88M
Dr. John F. Milligan Ph.D., 53
Pres and Chief Operating Officer
2.54M74.92M
Ms. Robin L. Washington , 51
Chief Financial Officer, Principal Accounting Officer and Exec. VP
1.54M5.27M
Dr. Norbert W. Bischofberger Ph.D., 58
Chief Scientific Officer and Exec. VP of R&D
2.05M26.58M
Mr. Kevin B. Young CBE, 56
Sr. Advisor
1.80M17.35M
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders